Company Filing History:
Years Active: 2006-2007
Title: Innovations in Cancer Detection by Dafang Wan
Introduction
Dafang Wan is a prominent inventor based in Shanghai, China, known for his significant contributions to cancer research and diagnostics. With a total of two patents, his work focuses on innovative methods for detecting susceptibility to hepatocarcinoma, a type of liver cancer.
Latest Patents
Dafang Wan's latest patents include a method for detecting hepatocarcinoma susceptibility by identifying a tumor-related gene located in the region of human chromosome 17 p. 13.3. This invention provides a diagnostic method for assessing an individual's risk of developing liver cancer by detecting the HC56 gene, its transcript, and/or protein. By comparing these with normal HC56 gene expressions, the method can indicate a higher likelihood of cancer in individuals. Additionally, he has developed a human hepatoma-associated protein and the polynucleotide encoding this polypeptide. This invention not only relates to the production of the polypeptide through recombinant methods but also outlines its application in diagnosing and treating various diseases, including cancer.
Career Highlights
Dafang Wan is affiliated with the Shanghai Cancer Institute, where he conducts research aimed at improving cancer diagnostics and treatments. His work has been instrumental in advancing the understanding of cancer susceptibility and the development of targeted therapies.
Collaborations
Dafang Wan collaborates with notable colleagues, including Jianren Gu and Xintai Zhao, who contribute to his research efforts in the field of cancer detection and treatment.
Conclusion
Dafang Wan's innovative approaches to cancer detection and treatment exemplify the critical role of inventors in advancing medical science. His patents reflect a commitment to improving patient outcomes through early diagnosis and targeted therapies.